Full-Time

Quality Engineer

Fortive

Fortive

5,001-10,000 employees

Global industrial tech company for safety

No salary listed

Everett, WA, USA

In Person

Bachelor's

Category
Manufacturing Quality & Test (1)
Required Skills
Six Sigma
ISO 9001
Word/Pages/Docs
Risk Management
Data Analysis
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides

Get referred to Fortive

See people who can refer or advise you

Requirements
  • BA/BS in Engineering or physical sciences preferred. Bachelor's degree preferred. Equivalent experience, and/or ASQ certifications accepted.
  • 3-5 years of related experience required
  • Must have knowledge of FDA QMSR, ISO 13485:2016, ISO 9001:2015, and/or ISO 17025:2017
  • Must have knowledge and experience in quality engineering concepts, including working knowledge of current process control and validation principles
  • Must be able to collaborate with other functions to collect and analyze data and conduct trending analysis.
  • Must have experience with Complaint, Nonconformance, Corrective/Preventive Actions, and Material Review Board processing.
  • Experience using standard quality tools i.e. Flow Charts, Pareto Charts, Histogram, Control Charts, Ishikawa Diagram, 5 Whys.
  • Business/financial acumen
  • Six sigma and process excellence tools/methodologies
  • Presentation skills and use of Power Point
  • Strong Quality Engineering skills with working knowledge of product design verification as well as product and process validation activities
  • Ability to communicate in a cross-cultural environment
  • Ability to effectively prioritize and manage multiple activities and responsibilities. Self-motivated.
  • Leadership ability in using problem solving techniques including root cause analysis and cause and effect analysis
  • Leadership ability in improving product reliability for products in partnership and various departments, such as R&D, Operations, Service
  • Fluent in MS Word and Excel
  • Strong working knowledge of industry standards such as IEC 62304, IEC 60601-1, IEC 61010, IEC 62353, various EMI/EMC requirements and/or knowledge of both regulatory requirements and other compliance areas
  • Proficient knowledge of both risk analysis and identification of effective risk controls. Strong understanding of appropriate Risk Management regulations and guidance standards, such as ISO 14971, ISO 31000, and FDA Guidance and thorough understanding in the application of risk management tools, such as System Risk Analysis, FMEA, and FTA.
Responsibilities
  • Ensure appropriate document control process is in place as it relates to medical activities.
  • Handle Complaints, Non-Conformances, Corrective/Preventive Actions, and Material Review Board activities.
  • Ensure effective interactions at department level and cross-functionally to effectively incorporate departmental activities into overall site/company strategies and quality systems.
  • Participate in project teams and meetings on behalf of the Global Quality & Regulatory Team in order to provide ideas, methods, or processes for site/corporate performance improvement.
  • Assists the development of essential QMS deliverables including, but not limited to complaint analysis, risk analysis, failure mode and effects analysis, CAPA, and process/equipment/software verification/validation.
  • Assist site quality manager to schedule and prepare management review meetings.
  • Coordinate the ‘Supplier Corrective Action Request’ (SCAR) program including monitoring response timeliness and effectiveness of corrective actions.
  • Execute New Product Introduction/Design Transfer activities in characterizing manufacturing processes for parts/components in development to ensure smooth transition from Research & Development to manufacturing, including participation and leadership of the development of equipment and process validation requirements (Failure Modes and Effects Analysis, Installation Qualification, Operational Qualification, Performance Qualification), using appropriate statistical tools and techniques
  • Spend time on the manufacturing floor to determine process improvements, participating in investigations, root cause analyses, corrective action planning, implementation activities and interfacing with all cross functional departments to increase product quality using recognized Six Sigma and Lean methodologies
  • Determine test requirements, test methods, sample sizes and statistical analysis for qualification/verification studies for manufacturing
  • Conduct and document internal audits and gap analyses against specified requirements.
  • Manage CAPA efforts and interact with internal and external customers to conduct investigations.
  • Collect, analyze, and assemble pertinent quality data for periodic reviews.
  • Participate in and support external audits as required.
  • Perform other job-related duties as assigned.

Fortive is a global industrial technology company that provides essential tools and systems in key safety and productivity sectors, including healthcare sterilization, industrial safety, predictive maintenance, and building environments. Its products combine hardware, software, and services to help customers improve safety, efficiency, and patient care. The company operates with a startup spirit at scale, guided by the Fortive Business System (FBS) to accelerate continuous improvement and positive impact. Fortive differentiates itself through its emphasis on mission-critical, field-ready solutions and a culture of collaboration, learning, and growth across about 10,000 employees worldwide. Its goal is to solve large-scale problems for customers and partners around the world, making workplaces safer, facilities more reliable, and healthcare providers more focused on patient care.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Washington DC, District of Columbia

Founded

2016

Get referred to Fortive

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 core revenue grew 6.7%, and Fortive raised full-year EPS guidance.
  • Fluke’s CertiFiber Max and CalStudio Conduit deepen data-center and lab workflow lock-in.
  • Fortive repurchased nearly $2 billion in four quarters, supporting EPS and investor confidence.

What critics are saying

  • EMEA revenue declined in Q2 2026, exposing Fortive to geopolitical and demand softness.
  • The 2024 restructuring runs through end-2026, keeping cost drag and workforce disruption alive.
  • Fortive’s 4.75% and 5.25% notes raise leverage costs, squeezing returns if growth stalls.

What makes Fortive unique

  • Fluke and ASP combine sticky calibration software with regulated healthcare consumables and services.
  • Fortive’s recurring revenue reached 50% in 2026, strengthening predictability versus cyclical industrial peers.
  • Olumide Soroye’s 2024 separation reset sharpened Fortive into higher-margin software and services.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

-17%

1 year growth

-17%

2 year growth

-17%
Yahoo Finance
Sep 10th, 2026
Fortive appoints Susan Main to board of directors

Fortive Corporation has appointed Susan Main to its board of directors, effective 9 September 2026, expanding the board from eight to nine members. Main will also serve on the Audit Committee. Main most recently served as senior vice president and chief financial officer of Teledyne Technologies from 2012 to 2023, where she led global finance operations and supported the company's growth strategy. She currently serves on the boards of Allegion and Ashland Inc. Board chair Shar Dubey highlighted Main's financial and operational expertise and public company director experience. Chief executive Olumide Soroye said her background in industrial technology would support Fortive's Accelerated strategy. Fortive is an Everett, Washington-based company that develops essential technologies across intelligent operating solutions and advanced healthcare solutions segments.

Yahoo Finance
Aug 21st, 2026
Fortive launches no-code calibration platform as software revenue hits 50%

Fortive subsidiary Fluke has launched CalStudio Conduit, a no-code workflow and integration platform for calibration laboratories. The tool automates lab workflows and connects existing systems without custom coding, targeting improved data handling across equipment, software, and quality systems. The launch supports Fortive's strategy to increase its software and services mix, which now represents 50% of recurring revenues. The US-based machinery company, with a market capitalisation of approximately $17.8 billion, has reported double-digit annual recurring revenue growth at key brands including Fluke. CalStudio Conduit aims to provide Fortive with deeper system integrations in tightly regulated calibration labs, where processes are sticky and switching costs are high. The platform positions Fortive against competitors such as Keysight Technologies and Tektronix in the test and measurement market.

Yahoo Finance
Aug 20th, 2026
Fortive beats Q2 revenue estimates by 2.5% as professional tools sector outperforms forecasts

Fortive reported Q2 revenues of $1.10 billion, up 7.9% year on year, exceeding analyst expectations by 2.5%. The professional tools and equipment manufacturer also beat analysts' EBITDA and EPS estimates. CEO Olumide Soroye highlighted core revenue growth of 6.7%, adjusted EBITDA growth of 12%, and adjusted EPS growth of 28%. The company completed approximately $200 million in share repurchases during the quarter, totalling roughly $2 billion over the past four quarters. Despite the strong results, Fortive's stock declined 7.7% following the earnings announcement, currently trading at $59.19. The broader professional tools and equipment sector, comprising nine tracked companies, collectively saw share prices fall 2.3% on average since latest earnings, though the group's Q2 revenues beat consensus estimates by 2.1%.

Yahoo Finance
Jul 29th, 2026
Fortive raises FY26 EPS guidance to $2.95-$3.05 on 6.7% core revenue growth

Fortive Corporation reported 6.7% core revenue growth in Q2 2026, driven by its "Fortive Accelerated" strategy focusing on innovation and recurring customer value. The company raised its full-year adjusted EPS guidance to $2.95–$3.05 and increased core growth expectations to approximately 4%, up from 2–3%. Gross margin reached 63%, down 100 basis points year-over-year due to product mix. North America performed strongly, whilst EMEA faced modest declines from macroeconomic uncertainty. Fortive executed approximately $200 million in share repurchases during Q2, totalling 11% of shares retired since launching "New Fortive" one year ago. The company acquired a majority stake in UV Smart to expand its medical disinfection portfolio. Key innovations included Gordian's Flash AI solution for construction cost estimating and FDA clearance for ASP's 50-pound expanded load capacity in robotic-assisted surgery.

Associated Press
Jul 29th, 2026
Fortive raises 2026 guidance to $2.95-$3.05 EPS on 28% earnings growth and $2B buybacks

Fortive Corporation reported strong second quarter 2026 results, with core revenue growth accelerating to 6.7% and adjusted earnings per share rising 28%. The company posted revenue of $1.10 billion, up 7.9% year-over-year, and adjusted EBITDA of $323 million, up 12%. President and CEO Olumide Soroye said the company completed approximately $200 million in share repurchases during the quarter, bringing total buybacks over the past four quarters to roughly $2 billion. Based on the strong first-half performance, Fortive raised its full-year 2026 adjusted earnings per share guidance range to $2.95 to $3.05. The company's Intelligent Operating Solutions segment generated $758 million in revenue, whilst Advanced Healthcare Solutions brought in $339 million. Operating cash flow reached $299 million for the quarter, with free cash flow of $271 million.